20th Anniversary of Pharmaceuticals—Recent Advances in Metallodrug Design and Application

Dear Colleagues,

The use of metal complexes as drugs has a long and varied history beginning with the use of gold, silver and copper salts for the treatment of various infectious diseases and ailments. In recent times, cis-platin has often been used as a prime example of the serendipitous discovery of a platinum-based coordination complex for the treatment of a number of cancers, and analogs and derivatives of this important complex continue to be studied extensively. Zinc-, ruthenium-, arsenic-, copper- and gold-based complexes have all entered clinical trials as anti-cancer agents in the past few years. Other applications of metal-containing compounds in medicine include metal–macrocycle complexes for photodynamic therapy (PDT) and magnetic resonance imaging (MRI). Metals are also essential elements in biology and include cobalt (cobalamin, vitamin B12), iron (hemoglobin) and magnesium (chlorophyll). In recognition of the 20th anniversary of Pharmaceuticals, the journal will publish a collection of both original research articles and reviews in a Special Issue highlighting recent advances in the design and application of metallodrugs in medicine and drug development. Topics include, but are not limited to, metal complexes as anti-cancer drugs, anti-viral and anti-bacterial therapeutics, photoactive compounds, ROS generators and anti-inflammatory agents.

Dr. Andrew Knight
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceuticals is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

• metallodrugs
• metal complexes
• transition metals
• anti-viral
• antibacterial
• gold
• silver
• ruthenium
• platinum
• organometallic
• drug discovery